Rebecca Roma
Psychiatry · Pittsburgh, PANPI 1366439747
Payments from drug & device makers
$3,326,695in general payments, 2019–2025
Across 4,270 payments — averaging $779.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$961K
- Alkermes, Inc.$737K
- Neurocrine Biosciences, Inc.$574K
- Johnson & Johnson$516K
- Teva Pharmaceuticals USA, Inc.$279K
- E.r. Squibb & Sons, L.L.C.$112K
- plus $147K from 5 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1,457 | $961,274 |
| Alkermes, Inc. | 1,028 | $737,180 |
| Neurocrine Biosciences, Inc. | 662 | $574,359 |
| Johnson & Johnson | 613 | $515,528 |
| Teva Pharmaceuticals USA, Inc. | 222 | $279,470 |
| E.r. Squibb & Sons, L.L.C. | 151 | $111,939 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 107 | $105,137 |
| H. Lundbeck A S | 4 | $30,201 |
| Lundbeck LLC | 15 | $10,607 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 7 | $735 |
| AbbVie(2 entities) | 4 | $265 |
How this compares
$3,326,695 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Other psychiatry in Pittsburgh
- Mayer AyyashPittsburgh$714K
- Leon RavinPittsburgh$106K
- Barbara NightingalePittsburgh$93K
- Robert HowlandPittsburgh$57K
- Mark FullerPittsburgh$38K
- Antoine DouaihyPittsburgh$30K
- Konasale PrasadPittsburgh$26K
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.